10.1006/niox.1999.0245 281 TarlanM.MoradiS.HeidarizadeN.TavallaeiO.KhazayelS.FarzaeiM
35 Active comparator studies have also shown similar or better A1C lowering with GLP-1 RAs compared with sulfonylureas, thiazolidinediones, and basal insulin
Sources Healthline: Weight Loss is Often a Losing Battle NIH: Glucagon-like peptide 1 (GLP-1) Cleveland Clinic: GLP-1 Agonists NIH: Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes American Diabetes Association: GLP-1 Receptor in Pancreatic -Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner NIH: GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P/Q-type Ca2+ channels NIH: Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function FDA: Concern Over Compounded GLP-1 Drugs FDA Label: OZEMPIC (Semaglutide Injection) Medication Guide FDA Label: WEGOVY (Semaglutide Injection) Medication Guide FDA Label: RYBELSUS (Oral Semaglutide) Medication Guide FDA Label: MOUNJARO (Tirzepatide Injection) Medication Guide FDA Label: ZEPBOUND (Tirzepatide Injection) Medication Guide Important Medical Information and Disclaimers Medical Disclaimer This information is for educational use only
MGF (mechano-growth factor, the IGF-1Ec splice variant) is a natural alternative splice product of the IGF-1 gene, upregulated by mechanical loading and muscle damage, distinguished by a unique C-terminal E-peptide
This immunomodulation may facilitate the cardiovascular protection reported in outcome studies
yes - if you are under 50 and your skin quality is good to moderately good, its very likely you can avoid - or at least put off - surgery using nonsurgical treatments
